Comparing adverse effects, short term outcomes, and cost implications of hyperthermic intravesical chemotherapy with Mitomycin-C and intravesical bacillus Calmette–Guerin instillation (Moscow-I strain) in the management of intermediate and high-risk nonmuscle invasive bladder cancer

Comparing adverse effects, short term outcomes, and cost implications of hyperthermic intravesical chemotherapy with Mitomycin-C and intravesical bacillus Calmette–Guerin instillation (Moscow-I strain) in the management of intermediate and high-risk nonmuscle invasive bladder cancer

Introduction: The recommended treatment for intermediate and high-risk nonmuscle invasive bladder cancer (NMIBC) is adjuvant intravesical bacillus Calmette–Guerin (BCG) instillation. However, up to 50% experience tumor recurrences even after adjuvant BCG, and many patients develop local or systemic...

Full description

Bibliographic Details
Main Authors: Yuvaraja B Thyavihally, Santosh S Waigankar, Preetham Dev, Ashish Asari, Abhinav P Pednekar, Nevitha Athikari, Abhijit Raut, Archan Khandekar, Naresh Badlani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Urology Annals
Subjects:
adjuvant bacillus calmette–guerin
adverse effects
bladder cancer
hyperthermic intra-vesical chemotherapy
nonmuscle invasive bladder cancer
outcomes
Online Access:http://www.urologyannals.com/article.asp?issn=0974-7796;year=2021;volume=13;issue=4;spage=424;epage=430;aulast=Thyavihally

Internet

http://www.urologyannals.com/article.asp?issn=0974-7796;year=2021;volume=13;issue=4;spage=424;epage=430;aulast=Thyavihally

Similar Items